Genmab A GMAB
NASDAQ GMAB
$43.79 +3.79 (+9.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genmab A (GMAB) Change in Intangibles (2023 - 2025)

Updated

Genmab A (GMAB) reported Change in Intangibles of -$2 million for the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Change in Intangibles (2023 - 2025) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Genmab A's Change in Intangibles came in at -$53 million; for the year ended Dec 31, 2025, it was -$37 million.

  • By year, Change in Intangibles came in at -$27 million in the year ended Dec 31, 2024, -$53 million in the year ended Dec 31, 2023, -$45 million in the year ended Dec 31, 2022 and -$28.47 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Change in Intangibles in data going back to the quarter ended Mar 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 995.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 437.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.32 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Genmab A 2.87 Bn -2.51 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -18.00 Mn
Sep 30, 2024 -2.00 Mn
Dec 31, 2023 11.00 Mn
API Access

Genmab A Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=GMAB&period=max&api_key=YOUR_API_KEY